Paul Fleissner, M.D., a board-certified orthopaedic and pediatric orthopaedic surgeon at Crystal Clinic Orthopaedic Center and chairman of the board, has performed the world’s first meniscus repair using RejuvaKnee from Regenity Biosciences. 

RejuvaKnee is a collagen-based meniscal implant, which recently received FDA clearance. In pre-clinical studies, it has supported a more complete recovery by facilitating the regeneration of native meniscal tissue (Source: Reginity Biosciences Data on File 2024). The procedure at Crystal Clinic Orthopedic Center was performed on a college-age athlete who suffered from chronic pain following a prior meniscectomy.

“Meniscal repair using this groundbreaking regenerative implant represents a real game-changer and a potential new standard of care for meniscal restoration,” said Dr. Fleissner. “It provides an outstanding and most durable solution for patients who have irreparable meniscus tears or have previously lost meniscus tissue. Extended wait time forces patients to suffer unnecessarily with prolonged pain and the inability to maintain their active lifestyles. Instead, this new implant is able to fit patients immediately, eliminating long wait times and protracted pain.”

In the coming weeks, Dr. Fleissner will perform several more meniscus repairs using this regenerative implant, which he believes will provide an immediate and long-lasting solution that will improve his patients’ quality of life.